Oxidative phosphorylation defects and Alzheimer's disease

Neurogenetics

Volumn 1, Issue 1, 1997, Pages 13-19

  Shoffner, John M ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

Alzheimer's disease; Cytochrome c oxidase; Glutamate neurotoxicity; Mitochondrial DNA; Oxidative phosphorylation; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; CYTOCHROME C OXIDASE; GLUTAMIC ACID; MITOCHONDRIAL DNA;

ALZHEIMER DISEASE; BIOLOGICAL MODEL; ENZYMOLOGY; GENETICS; HUMAN; MUTATION; OXIDATIVE PHOSPHORYLATION; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX IV; GLUTAMIC ACID; HUMANS; MODELS, BIOLOGICAL; MUTATION; OXIDATIVE PHOSPHORYLATION;

EID: 0031128798     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100480050002     Document Type: Review

References (103)

1. Whitehouse, P.J., Price, D.L., Struble, R.G., Clark, A.W., Coyle, J.T., and DeLong, M.R. (1982) Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science, 215, 1237-1239.
2. Roses, A.D. (1997) A model of susceptibility polymorphism for complex diseases: Apolipoprotein E and Alzheimer disease. Neurogenetics, 1, 3-11.
3. Mumm, S., Whyte, M.P., Thakker, R.V., Buetow, K.H., and Schlessinger, D. (1997) mtDNA analysis shows common ancestry in two kindreds with X-linked recessive hypoparathyroidism and reveals a heteroplasmic silent mutation. Am. J. Hum. Genet., 60, 153-159.
4. Howell, N., Kubacka, I., and Mackey, D.A. (1996) How rapidly does the human mitochondrial genome evolve? Am. J. Hum. Genet., 59, 501-509.
5. Lynch, M. (1996) Mutation accumulation in transfer RNAs: Molecular evidence for Muller's ratchet in mitochondrial genomes. Mol. Biol. Evol., 13, 209-220.
6. Vigilant, L., Stoneking, M., Harpending, H., Hawkes, K., and Wilson, A.C. (1991) African populations and the evolution of human mitochondrial DNA. Science, 253, 1503-1507.
7. Stoneking, M., Jorde, L.B., Bhatia, K., and Wilson, A.C. (1990) Geographic variation in human mitochondrial DNA from Papua New Guinea. Genetics, 124, 717-723.
8. Cann, R.L., Stoneking, M., and Wilson, A.C. (1987) Mitochondrial DNA and human evolution. Nature, 325, 31-36.
9. Shoffner, J.M. and Wallace, D.C. (1995) Oxidative phosphorylation diseases. In The Metabolic and Molecular Bases of Inherited Disease, C.R. Scriver, et al., eds. 1995, McGraw-Hill Information Services Company: New York, p. 1535-1610.
10. Tatuch, Y., Christodoulou, J., Feigenbaum, A., Clark, J.T.R., Wherret, J., Smith, C., Rudd, N., Petrova-Benedict, R., and Robinson, B.H. (1992) Heteroplasmic mitochondrial DNA mutation (T to G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am. J. Hum. Genet., 50, 852-858.
11. Shoffner, J.M., Fernhoff, P.M., Krawiecki, N.S., Caplan, D.B., Holt, P.J., Koontz, D.A., Takei, Y., Newman, N.J., Ortiz, R.G., Polak, M., Ballinger, S.W., Lott, M.T., and Wallace, D.C. (1992) Subacute necrotizing encephalopathy: oxidative phosphorylation defects and the ATPase 6 point mutation. Neurology, 42, 2168-2174.
12. Shoffner, J.M., Lott, M.T., Lezza, A.M., Seibel, P., Ballinger, S.W., and Wallace, D.C. (1990) Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell, 61, 931-937.
13. Goto, Y., Nonaka, I., and Horai, S. (1990) A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature, 348, 651-653.
14. Newman, N.J. (1991) Leber's hereditary optic neuropathy. Ophthalmol. Clinics North Am., 4, 431-447.
15. Cortopassi, G.A. and Arnheim, N. (1990) Detection of a specific mitochondrial deletion in tissues of older individuals. Nucleic Acids Res., 18, 6927-6933.
16. Arnheim, N. and Cortopassi, G. (1992) Deleterious mitochondrial DNA mutations accumulate in aging human tissues. Mutation Res., 275, 157-167.
17. Mecocci, P., MacGarvey, U., Kaufman, A.E., Koontz, D., Shoffner, J.M., Wallace, D.C., and Beal, M.F. (1993) Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol., 34, 609-616.
18. Blass, J.P. and Gibson, G.E. (1991) The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease. Rev. Neurol., 147, 513-525.
19. Brown, G.G., Levine, S.R., Gorell, J.M., Pettegrew, J.W., Gdowski, J.W., Buen, J.A., Helpern, J.A., and Welch, K.M.A. (1989) In vivo 31-PNMR profiles of Alzheimer's disease and multiple subcortical infarct dementia. Neurology, 39, 1423-1427.
20. Chace, T.N., Foster, N.L., Fedio, P., Brooks, R., Mansi, L., and Di Chiro, G. (1984) Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography. Ann. Neurol., 15 (Suppl.), S170-S174.
21. Frackowiack, R.S.J., Pozzilli, C., Legg, N.J., Duboulay, G.H., Marshall, J., Lenzi, G.L., and Jones, T. (1981) Regional oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain, 104, 753-778.
22. Farkas, T., Ferris, S.H., Wolf, A.P., De Leon, M.J., Christman, D.R., Reisberg, B., Alavi, A., Fowler, J.S., George, A.E., and Reivich, M. (1982) 18-F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia. Am. J. Psychiatry, 139, 352-353.
23. Benson, D.F., Kuhl, D.E., Phelps, M.E., Cummings, J.L., and Tsai, S.Y. (1983) The fluorodeoxyglucose 18-F scan Alzheimer and multi-infarct dementia. Arch. Neurol., 40, 711-714.
24. De Kosky, S.T., Shih, W.J., Schmitt, F.A., Coupala, J., and Kirkpatrick, C. (1990) Assessing utility of single photon emission computed tomography (SPECT) scan in Alzheimer disease: correlation with cognitive severity. Alzheimer Dis. Assoc. Dis., 4, 14-23.
25. Perani, D., Di Piero, V., Vallar, G., Cappa, S., Messa, C., Bottini, G., Berti, A., Passafiume, D., Scarlato, G., Gerundini, P., Lenzi, G.L., and Fazio, F. (1988) Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. J. Nucl. Med., 29, 1507-1514.
26. Nyback, H., Nyman, H., Blomqvist, G., Sjogren, I., and Stone-Elander, S. (1991) Brain metabolism in Alzheimer's dementia: studies of 11-C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects. J. Neurol. Neurosurg. Psychiatry, 54, 672-678.
27. McGeer, P.L., Kamo, H., Harrop, R., Li, D.K.B., Tuokko, H., McGeer, E.G., Adam, M.J., and Ammann, W. (1986) Positron emission tomography in patients with clinically diagnosed Alzheimer's disease. Can. Med. Assoc. J., 134, 597-607.
28. Kumar, A., Schapiro, M.B., Grady, C., Haxby, V.J., Wagner, E., Salerno, A.J., Friedland, R.P., and Rapoport, S.I. (1984) High resolution PET studies in Alzheimer's disease. Neuropsychopharmacology, 4, 35-46.
29. Haxby, J.V., Grady, C.L., Duara, R., Schlageter, N., Berg, G., and Rapoport, I. (1986) Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's type dementia. Arch. Neurol., 43, 882-885.
30. Sims, N.R., Finegan, J.M., Blass, J.P., Bowen, D.M., and Neary, D. (1987) Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res., 436, 30-38.
31. Terry, R.D. and Wisniewski, H.M. (1972) Ultrastructure of senile dementia and of experimental analogs. In Aging and the Brain, C.M. Gaitz, ed. Plenum Press: New York. p. 89-116.
32. Hansen, L.A., Masliah, E., Terry, R.D., and Mirra, S.S. (1989) A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol., 78, 194-201.
33. Saraiva, A.A., Borges, M.M., Madeira, M.D., Tavares, M.A., and Paula-Barbosa, M.M. (1985) Mitochondrial abnormalities in cortical dendrites from patients with Alzheimer's disease. J. Submicrosc. Cytol., 17, 459-464.
34. Parnetti, L., Gaiti, A., Polidori, M.C., Brunetti, M., Palumbo, B., Chionne, F., Cadini, D., Cecchetti, R., and Senin, U. (1995) Increasedcerebrospinal fluid pyruvate levels in Alzheimer's disease. Neurosci. Lett., 199, 231-233.
35. Sorbi, S., Piacentini, S., Fani, C., Tonini, S., Marini, P., and Amaducci, L. (1989) Abnormalities of mitochondrial enzymes in hereditary ataxias. Acta Neurol. Scand., 80, 103-110.
36. Sorbi, S., Bird, E.D., and Blass, J.P. (1983) Decreased pyruvate dehydrogenase activity in Huntington and Alzheimer brain. Ann. Neurol., 13, 72-78.
37. Mizuno, Y., Matuda, S., Yoshino, H., Mori, H., Hattori, N., and Ikebe, S.I. (1994) An immunohistochemical study on α-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann. Neurol., 35, 204-210.
38. Mizuno, Y., Saitoh, T., and Sone, N. (1987) Inhibition of mitochondrial alpha-ketoglutarate dehydrogenase by 1-methyl-4-phenylpyridinum ion. Biochem. Biophys. Res. Commun., 143, 971-976.
39. Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., Sato, T., Oya, H., Ozawa, T., and Kagawa, Y. (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun., 163, 1450-1455.
40. Mastrogiacomo, F. and Kish, S.J. (1994) Cerebellar α-ketoglutarate dehydrogenase activity is reduced in spinocerebellar ataxia type 1. Ann. Neurol., 35, 624-626.
41. Parker, W.D., Boyson, S.J., Luder, A.S., and Parks, J.K. (1990) Evidence for a defect in NADH:ubiquinone oxidoreductase (complex I) in Huntington's disease. Neurology, 40, 1231-1234.
42. Parker, W.D., Boyson, S.J., and Parks, J.K. (1989) Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol., 26, 719-723.
43. Shoffner, J.M., Watts, R.L., Juncos, J.L., Torroni, A., and Wallace, D.C. (1991) Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann. Neurol., 30, 332-339.
44. Blass, J.P., Kark, R.A.P., Menon, N., and Harris, S.H. (1976) Decreased activities of the pyruvate and ketoglutarate dehydrogenase complexes in fibroblasts from fibe patients with Friedreich's ataxia. N. Engl. J. Med., 295, 62-66.
45. Hansford, R.G. and Castro, F. (1985) Role of Ca+2 in pyruvate dehydrogenase interconversion in brain mitochondria and synaptosomes. Biochem. J., 227, 129-136.
46. Browning, M., Baudry, M., Bennet, W.F., and Lynch, G. (1981) Phosphorylation-mediated changes in pyruvate dehydrogenase activity influence pyruvate-supported calcium accumulation by brain mitochondria. J. Neurochem., 36, 1932-1940.
47. Blass, J.P. and Gibson, G.E. (1979) Consequences of mild, graded hypoxia. Adv. Neurol., 26, 229-253.
48. Perry, E.K., Perry, R.H., Tomlinson, B.E., Blessed, G., and Gibson, P.H. (1980) Coenzyme-A-acetylating enzymes in Alzheimer's disease: possible cholinergic 'compartment' of pyruvate dehydrogenase. Neurosci. Lett., 18, 105-110.
49. Sheu, K.-F.R., Kim, Y.-T., Blass, J.P., and Weksler, M.E. (1985) An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain. Ann. Neurol., 17, 444-449.
50. Butterworth, R.F. and Besnard, A.M. (1990) Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease. Metab. Brain Dis., 5, 179-184.
51. Gibson, G.E., Sheu, K.F.R., Blass, J.P., Baker, A., Carlson, K.C., Harding, B., and Perrino, P. (1988) Reduced activities of thiamine dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch. Neurol., 45, 836-840.
52. Mastrogiacomo, F., Bergeron, C., and Kish, S.J. (1993) Brain α-ketoglutarate dehydrogenase activity in Alzheimer's disease. J. Neurochem., 61, 2007-2014.
53. Mastrogiacomo, F., Lindsay, J.G., Bettendorf, L., Rice, J., and Kish, S.J. (1996) Brain protein and α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. Ann. Neurol., 39, 592-598.
54. Parker, W.D., Filley, C.M., and Parks, J.K. (1990) Cytochrome oxidase deficiency in Alzheimer's disease. Neurology, 40, 1302-1303.
55. Van Zuylen, A.J., Bosman, G.J.C.G.M., Ruitenbeek, W., Van Kalmthout, P.J.C., and De Grip, W.J. (1992) No evidence for reduced thrombocyte cytochrome oxidase activity in Alzheimer's disease. Neurology, 42, 1246-1247.
56. Parker, W.D., Mahr, N.J., Filley, C.M., Parks, J.K., Hughes, D., Young, D.A., and Cullum, C.M. (1994) Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology, 44, 1086-1090.
57. Parker, W.D., Parks, J., Filley, C.M., and Kleinschmidt-DeMasters, B.K. (1994) Electron transport chain defects in Alzheimer's disease brain. Neurology, 44, 1090-1096.
58. Parker, W.D. and Parks, J.K. (1995) Cytochrome c oxidase in Alzheimer's diseaes brain: Purification and characterization. Neurology, 45, 482-486.
59. Cooper, J.M., Wischik, C., and Schapira, A.H.V (1993) Mitochondrial function in Alzheimer's disease. Lancet, 341, 969-970.
60. Reichmann, H., Florke, S., Hebenstreit, G., Schrubar, H., and Riederer, P. (1993) Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease. J. Neurol., 240, 377-380.
61. Bennett, M.C., Diamond, D.M., Stryker, S.L., Parks, J.K., and Parker, W.D. (1992) Cytochrome c oxidase inhibition: A novel animal model of Alzheimer's disease. J. Geriatr. Psychiatry Neurol., 5, 93-101.
62. Horton, J.C. and Hubel, D.H. (1981) Regular patchy distribution of cytochrome c oxidase staining in primary visual cortex of macaque monkey. Nature, 292, 762-764.
63. Wong-Riley, M.T.T., Merzenich, M.M., and Leake, P.A. (1978) Changes in endogenous enzymatic reactivity to DAB induced by neuronal inactivity. Brain Res., 141, 185-192.
64. Wong-Riley, M. (1979) Changes in the visual system of monocularly sutured or enucleated cats demostrable with cytochrome c oxidase histochemistry. Brain Res., 171, 11-28.
65. Kristal, B.S., Chen, J., and Yu, B.P. (1994) Sensitivity of mitochondnal transcription to different free radical species. Free Radical Biol. Med., 16, 323-329.
66. Simonian, N.A. and Hyman, B.T. (1993) Functional alterations in Alzheimer's disease: Diminution of cytochrome oxidase in the hippocampal formation. J. Neuropath. Exp. Neurol., 52, 580-585.
67. Chandrasekaran, K., Stoll, J., Brady, D.R., and Rapoport, S.I. (1992) Distribution of cytochrome oxidase (COX) activity and mRNA in monkey and human brain: COX mRNA distribution correlates with neurons vulnerable to Alzheimer pathology. Soc. Neurosci. Abstracts., 18, 557.
68. Askansas, V., McFerrin, J., Baque, S., Alvarez, R.B., Sarkozi, E., and Engel, W.K. (1996) Transfer of β-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. Proc. Natl. Acad. Sci. USA, 93, 1314-1319.
69. Kaneko, I., Yamada, N., Sauraba, Y., Kamenosono, M., and Tutumi, S. (1995) Suppression of mitochondrial succinate dehydrogenase, a primary target of β-amyloid, and its derivative racemized at Ser residue. J. Neurochem., 65, 2585-2593.
70. Shoffner, J.M., Brown, M.D., Torroni, A., Lott, M.T., Cabell, M.F., Mirra, S.S., Beal, M.F., Yang, C.-C., Gearing, M., Salvo, R., Watts, R.L., Juncos, J.L., Hansen, L.A., Grain, B.J., Fayad, M., Reckord, C.L., and Wallace, D.C. (1993) Mitochondrial DNA mutations associated with Alzheimer's and Parkinson's disease. Genomics, 17, 171-184.
71. Brown, M.D., Shoffner, J.M., Kim, Y., Jun, A., Graham, B., Cabell, M., Gurley, D., and Wallace, D.C. (1996) Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients. Am. J. Med. Genet., 61, 283-289.
72. Cortopassi, G.A. and Hutchin, T.P. (1994) Germline inheritance of a rare mtDNA variant leads to greatly increased risk for Alzheimer's disease. Am. J. Hum. Genet., 55, A149.
73. Wragg, M.A., Talbot, C.J., Morris, J.C., Lendon, C.L., and Goate, A.M. (1995) No association found between Alzheimer's disease and a mitochondrial tRNA glutamine variant. Neuroscience Lett., 201, 107-110.
74. Davis, R.E., Miller, S., Herrnstadt, C., Ghosh, S., Fahy, E., Galasko, D., Thal, L.J., and Parker, W.D. (1996) Specific point mutations in mitochondrial cytochrome c oxidase genes are associated with sporadic Alzheimer's disease. Neurology, 46, A276.
75. Sheu, K.-F.R., Sarkar, P., Wasco, W., Tanzi, R., and Blass, J.P. (1996) A gene locus of dihydrolipoyl succinyltransferase (DLST) is associated with Alzheimer's disease. J. Neurochem., 66, S10.
76. Astrand, I., Astrand, P.O., Hallback, I., and Kilborn, A. (1973) Reduction in maximal oxygen uptake with age. J. Appl. Physiol., 35, 649-654.
77. Bittles, A.H. (1989) The role of mitochondria in cellular ageing. In Human, Ageing and Later Life, A.M. Warnes, ed. Edward Arnold: London. p. 29-37.
78. Kiessling, K.H., Pilstrom, I., Karlsson, J., and Piehl, K. (1973) Mitochondrial volume in skeletal muscle from young and old physically untrained and trained healthy men and from alcoholics. Clin. Sci., 44, 547-554.
79. Trounce, I., Byrne, E., and Marzuki, S. (1989) Decline in skeletal muscle mitochondrial respiratory chain function: Possible factor in ageing. Lancet, i, 637-639.
80. Cardellach, F., Galofre, J., Cusso, R., and Urbano-Marquez, A. (1989) Decline in skeletal muscle mitochondrial respiration chain function with ageing. Lancet, ii, 44-45.
81. Abu-Erreish, G.M. and Sanadi, D.R. (1978) Age-related changes in cytochrome concentration of myocardial mitochondria. Mech. Ageing Dev., 7, 425-432.
82. Tauchi, H. and Sato, T. (1985) Cellular changes in senescence: possible factors influencing the process of cellular ageing. In Thresholds in Ageing, M. Bergener, M. Ermini, and H.B. Stahelin, eds. Academic Press: London. p. 91-113.
83. Muller-Hocker, J. (1989) Cytochrome c oxidase deficient cardiomyocytes in the human heart. An age-related phenomenon. Am. J. Pathol., 134, 1167-1171.
84. Muller-Hocker, J. (1990) Cytochrome c oxidase deficient fibers in the limb muscle and diaphragm of a man without muscular disease: an age-related alteration. J. Neurol. Sci., 100, 14-21.
85. Muller-Hocker, J., Schneiderbanger, K., Stefani, F.H., and Kadenbach, B. (1992) Progressive loss of cytochrome c oxidase in the human extraocular muscles in ageing-a cytochemical-immunohistochemical study. Mutation Res., 275, 115-124.
86. Miquel, J., Economos, A.C., Fleming, J., and Johnson, J.E.J. (1980) Mitochondrial role in cell aging. Exp. Gerentol., 15, 575-591.
87. Ikebe, S., Tanaka, M., Ohno, K., Sato, W., Hattori, K., Kondo, T., Mizuno, T., and Ozawa, T. (1990) Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochem. Biophys. Res. Commun., 170, 1044-1048.
88. Corral-Debrinski, M., Horton, T., Lott, M.T., Shoffner, J.M., Beal, M.F., and Wallace, D.C. (1992) Mitochondrial DNA deletions in human brain: Regional variability and increase with advanced age. Nature Genet., 2, 324-329.
89. Soong, N.W., Hinton, D.R., Cortopassi, G., and Arnheim, N. (1992) Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nature Genet., 2, 318-323.
90. Corral-Debrinski, M., Shoffner, J.M., Lott, M.T., and Wallace, D.C. (1992) Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat. Res., 275, 169-180.
91. Corral-Debrinski, M., Stepien, G., Shoffner, J.M., Lott, M.T., Kanter, K., and Wallace, D.C. (1991) Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease. JAMA, 266, 1812-1816.
92. Hattori, K., Tanaka, M., Sugiyama, S., Obayashi, T., Ito, T., Satake, T., Hanaki, Y., Asai, J., Nagano, M., and Ozawa, T. (1991) Age-dependent increase in deleted mitochondrial DNA in the human heart: possible contributory factor to presbycardia. Am. Heart J., 121, 1735-1742.
93. Sugiyama, S., Hattori, K., Hayakawa, M., and Ozawa, T. (1991) Quantitative analysis of age associated accumulation of mitochondrial DNA with deletion in human hearts. Biochem. Biophys. Res. Commun., 180, 894-899.
94. Ozawa, T., Tanaka, M., Sugiyama, S., Hattori, K., Ito, T., Ohno, K., Takahashi, A., Sato, W., Takada, G., Mayumi, B., Yamamoto, K., Adachi, K., Koga, Y., and Toshima, H. (1990) Multiple mitochondrial DNA deletions exist in cardiomyocytes of patients with hypertrophic or dilated cardiomyopathy. Biochem. Biophys. Res. Commun., 170, 830-836.
95. Katayama, M., Tanaka, M., Yamamoto, H., Ohbayashi, T., Nimura, Y., and Ozawa, T. (1991) Deleted mitochondrial DNA in the skeletal muscle of aged individuals. Biochem. Int., 25, 47-56.
96. Yen, T.-C., Su, J.-H., King, K.-L., and Wei, Y.-H. (1991) Ageing-associated 5 kb deletion in human liver mitochondrial DNA. Biochim. Biophys. Res. Commun., 178, 124-131.
97. Cortopassi, G.A., Shibata, D., Soong, N.-W., and Arnheim, N. (1992) A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging tissues. Proc. Natl. Acad. Sci. USA, 89, 7370-7374.
98. Hayakawa, M., Torii, K., Sugiyama, S., Tanaka, M., and Ozawa, T. (1991) Age-associated accumulation of 8-hydroxydeoxyguanosine in mitochondrial DNA of human diaphragm. Biochem. Biophys. Res. Commun., 179, 1023-1029.
99. Corral-Debrinski, M., Horton, T., Lott, M.T., Shoffner, J.M., McKee, A.C., Beal, M.F., Graham, B.H., and Wallace, D.C. (1994) Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics, 23, 471-476.
100. Sheu, K.-F.R., Chen, X., and Schon, E.A. (1994) Are there deletions of mitochondrial DNA in Alzheimer's disease. Neurology, 44, A390.
101. Blanchard, B.J., Park, T., Fripp, W.J., Lerman, L.S., and Ingram, V.M. (1993) A mitochondrial DNA deletion in normally aging and in Alzheimer brain tissue. NeuroReport, 4, 799-802.
102. Beal, M.F. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol., 31, 119-130.
103. Yankner, B.A. (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron, 16, 921-932.